Performance
Stock factor profile
Arvee Laboratories (India) Ltd
ARVEE · Commodities · Chemicals & Petrochemicals
Arvee Laboratories (India) Ltd. provides chemical products, which includes polymer modifiers, contrast media and drug intermediates. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2018-02-22. The firm is primarily engaged in the manufacturing of Polymer Modifiers, Contrast Media Intermediates and Drug Intermediates. The Company’s Polymer Modifiers include 5-Sulfoisophthalic Acid Mono Sodium Salt, Dimethyl 5-Sodiosulfoisophthalate and 5-Sulfoisophthalic Acid Mono Lithium Salt. Its Contrast Media Intermediates include 5-Nitroisophthalic acid, 5-Aminoisophthalic acid, Dimethyl 5-Nitroisophthalate, 5-Hydroxyisophthalic acid, Monomethyl 5-Nitroisophthalate, 3,5-Diamino Benzoic Acid, Dimethyl 5-Aminoisophthalate and 3,5-Dinitrobenzoic acid. Its Drug Intermediates include 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde, 4-Amino Pyridine and 2-Chloro-5-Nitrobenzoic Acid.
Equity review factors
Factor profile
Factor scores are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags and screen results for Arvee Laboratories (India) Ltd are part of the Wright portfolio review.
Run your free portfolio reviewFundamental snapshot
Fundamentals at a glance
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.